Jaco Botha

<p>Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis</p>

Uma Ramaswami, Michael Beck, Derralynn Hughes et al. · Drug Design Development and Therapy · 2019 · 44 citations · Full text

Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS)

Joseph Muenzer, Jaco Botha, Paul Harmatz et al. · Orphanet Journal of Rare Diseases · 2021 · 27 citations · Full text

Hypercalcaemia in the Johannesburg Hospital. Differential diagnosis and physician awareness of primary hyperparathyroidism.

Terry Diamond, Jaco Botha, W.J.H. Vermaak et al. · PubMed · 1987 · 13 citations

Serum Profiles, Physician Awareness, Johannesburg Hospital +11

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease

Markus Cybulla, Sandro Feriozzi, Aleš Linhart et al. · Journal of Clinical Medicine · 2022 · 13 citations · Full text

FindZebra online search delving into rare disease case reports using natural language processing

Valentin Liévin, Jonas Meinertz Hansen, Allan M. Lund et al. · PLOS Digital Health · 2023 · 10 citations · Full text